Phase 1 ALKS 1140 in Healthy Adults

Clinical trial NCT05019105 · TERMINATED

Trial details

NCT number: NCT05019105
Sponsor: Alkermes, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Diseases

Start date: 2021-10-13
Primary completion: 2022-08-23
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.